A novel BRCA1 mutation in a patient with breast and ovarian cancer: A case report
Keywords: 
BRCA1
Breast cancer
Novel mutation
Ovarian cancer
Issue Date: 
2013
Publisher: 
Spandidos Publications
ISSN: 
1792-1074
Citation: 
Salgado J, Santisteban M, Gutierrez C, Gil C, Robles M, Viedma A, et al. A novel BRCA1 mutation in a patient with breast and ovarian cancer: A case report. Oncol Lett. 2013 September;6(3):725–727.
Abstract
Germline mutations in the human breast cancer genes BRCA1 and BRCA2 account for a substantial proportion of familial, early-onset breast and ovarian cancers. The present study reports a novel disease-causing BRCA1 mutation, nucleotide 3020insCT/c.2901insCT, in a 55-year-old Spanish female with breast and ovarian cancer. This frameshift mutation creates a premature stop codon at amino acid 1000, leading to a truncated BRCA1 protein. To the best of our knowledge, this mutation has not been previously described in the Breast Cancer Information Core (BIC) database or the published literature

Files in This Item:
File: 
ol-06-03-0725.pdf
Description: 
Size: 
386,83 kB
Format: 
Adobe PDF


Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.